Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)

This study has been completed.
Information provided by (Responsible Party):
Swedish Orphan Biovitrum ( Amgen ) Identifier:
First received: May 20, 2005
Last updated: August 10, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2003
  Estimated Primary Completion Date: No date given